Host: |
Rabbit |
Applications: |
WB/IP |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-PBRM1 (1-230) is suitable for use in Western Blot and Immunoprecipitation research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IP 1:20-1:500 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PBRM1 |
Gene ID: |
55193 |
Uniprot ID: |
PB1_HUMAN |
Immunogen Region: |
1-230 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-230 of human PBRM1 (NP_060783.3). |
Immunogen Sequence: |
MGSKRRRATSPSSSVSGDFD DGHHSVSTPGPSRKRRRLSN LPTVDPIAVCHELYNTIRDY KDEQGRLLCELFIRAPKRRN QPDYYEVVSQPIDLMKIQQK LKMEEYDDVNLLTADFQLLF NNAKSYYKPDSPEYKAACKL WDLYLRTRNEFVQKGEADDE DDDEDGQDNQGTVTEGSSPA YLKEILEQLLEAIVVATNPS GRLISELFQKLPSKVQYPDY YAIIKEPIDL |
Tissue Specificity | Widely expressed. |
Function | Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation. |
Protein Name | Protein Polybromo-1Hpb1Brg1-Associated Factor 180Baf180Polybromo-1d |
Database Links | Reactome: R-HSA-3214858Reactome: R-HSA-8939243 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Protein Polybromo-1 antibodyAnti-Hpb1 antibodyAnti-Brg1-Associated Factor 180 antibodyAnti-Baf180 antibodyAnti-Polybromo-1d antibodyAnti-PBRM1 antibodyAnti-BAF180 antibodyAnti-PB1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance